2021
DOI: 10.1177/0145561320981442
|View full text |Cite
|
Sign up to set email alerts
|

Resection of Carotid Body Tumors in Patients of Advanced Age: Experience From a Single Center

Abstract: Introduction: Resection of carotid body tumor (CBT) in patients of advanced ages has not been appreciated. Objectives: This study aims to assess the clinical characteristics and perioperative comorbidities for CBT resection in patients of advanced age and to validate the application of an “isolated island” technique for extirpation of CBT. Methods: Eight patients of advanced age (≥60 years) who underwent CBT resection were enrolled as the study group (SG). Another 29 patients of younger age (<45 years old) … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 25 publications
0
3
0
Order By: Relevance
“…Therefore, a bias may be present for usage of a 3-D model for establishment of a surgical plan. In addition, the decision to resect these multiple paragangliomas is determined by multiple factors, 26 critical multidisciplinary team discussion and the sufficient experience of the surgical team are prerequisites as part of the decision-making process for each case. 26…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, a bias may be present for usage of a 3-D model for establishment of a surgical plan. In addition, the decision to resect these multiple paragangliomas is determined by multiple factors, 26 critical multidisciplinary team discussion and the sufficient experience of the surgical team are prerequisites as part of the decision-making process for each case. 26…”
Section: Discussionmentioning
confidence: 99%
“…Observation, therefore, may be indicated for small, benign, asymptomatic tumors, elderly patients, and/or those with surgical comorbidities ( Heesterman et al 2017 ). Nevertheless, for patients ≥60 years old and with minimal comorbidities, surgery remains a viable option at high-volume head and neck cancer centers, with outcomes comparable to patients of younger age ( Li et al 2021 ). The median time to growth is reportedly 1.5 years; surgery may therefore be delayed even in younger patients, if asymptomatic ( Heesterman et al 2017 ).…”
Section: Introductionmentioning
confidence: 99%
“…comorbidities, surgery remains a viable option at high-volume head and neck cancer centers, with outcomes comparable to patients of younger age(Li et al, 2021). The median time to growth is reportedly 1.5 years; surgery may therefore be delayed even in younger patients, if asymptomatic(Heesterman et al, 2017).…”
mentioning
confidence: 99%